Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

Market Cap	11.57B
Revenue (ttm)	4.28B
Net Income (ttm)	721.29M
Shares Out	861.03M
EPS (ttm)	0.84
PE Ratio	16.00
Forward PE	16.67
Dividend	0.30 (2.18%)
Ex-Dividend Date	May 24, 2024

Volume	15,523,199
Average Volume	16,651,505
Open	13.00
Previous Close	13.74
Day's Range	13.00 - 13.79
52-Week Range	9.88 - 14.03
Beta	0.09
RSI	62.42
Earnings Date	Apr 3, 2025

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 3,909
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002020

Financial Performance

In 2023, SHE:002020's revenue was 4.00 billion, an increase of 5.79% compared to the previous year's 3.78 billion. Earnings were 618.90 million, a decrease of -6.55%.